Preserving the Liver for Second-Line Treatment of Hepatocellular Carcinoma

被引：0
|
作者：
Lencioni, Riccardo [1 ,2 ]
机构：
[1] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Intervent Radiol,Intervent Radiol, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Intervent Radiol,Clin & Translat Res, Miami, FL 33136 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2016年 / 14卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 8
页数：3
相关论文
共 50 条
  • [21] Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2018, 7 (04) : 305 - 311
  • [22] Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
    Granito, Alessandro
    Marinelli, Sara
    Terzi, Eleonora
    Piscaglia, Fabio
    Renzulli, Matteo
    Venerandi, Laura
    Benevento, Francesca
    Bolondi, Luigi
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (06) : 518 - 522
  • [23] Hepatocellular Carcinoma: Successes with Regorafenib in Second-line Therapy
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (05):
  • [24] Cabozantinib as a Second-Line Agent in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2018, 7 (02) : 123 - 133
  • [25] Novel Second-Line Treatments for Hepatocellular Carcinoma: Discussion
    Frenette, Catherine T.
    Lencioni, Riccardo
    Finn, Richard S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 12 - 13
  • [26] Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma
    Takada, Yasutsugu
    Ueda, Mikiko
    Ito, Takashi
    Sakamoto, Seisuke
    Haga, Hironori
    Maetani, Yoji
    Ogawa, Kohei
    Kasahara, Mureo
    Oike, Fumitaka
    Egawa, Hiroto
    Tanaka, Koichi
    LIVER TRANSPLANTATION, 2006, 12 (06) : 912 - 919
  • [27] Novel liver-targeted antimetabolic pronucleotide for advanced, second-line hepatocellular carcinoma and liver metastasis
    Parsy, C.
    Dousson, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S114 - S114
  • [28] Second-line treatment of metastatic prostatic carcinoma
    Newling, DWW
    UROLOGICAL RESEARCH, 1997, 25 (Suppl 2): : S73 - S78
  • [29] Second-line treatment of advanced neuroendocrine carcinoma
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 304 - 304
  • [30] Second-line treatment of metastatic prostatic carcinoma
    D. W. W. Newling
    Urological Research, 1997, 25 : S73 - S78
12345